Electromed Stock Shares Outstanding
| ELMD Stock | USD 18.62 0.49 2.70% |
Fundamental analysis of Electromed allows traders to better anticipate movements in Electromed's stock price by examining its financial health and performance throughout various phases of its business cycle.
Electromed | Build AI portfolio with Electromed Stock |
Electromed Company Shares Outstanding Analysis
Electromed's Outstanding Shares are shares of common stock of a public company that were purchased by investors after they were authorized and issued by the company to the public. Outstanding Shares are typically reported on fully diluted basis, including exotic instruments such as options, or convertibles bonds.
Current Electromed Shares Outstanding | 8.39 M |
Most of Electromed's fundamental indicators, such as Shares Outstanding, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Electromed is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Outstanding shares that are stated on company Balance Sheet are used when calculating many important valuation and performance indicators including Return on Equity, Market Cap, EPS and many others.
| Competition |
Based on the latest financial disclosure, Electromed has 8.39 M of shares currently outstending. This is 95.35% lower than that of the Health Care Equipment & Supplies sector and 95.21% lower than that of the Health Care industry. The shares outstanding for all United States stocks is 98.53% higher than that of the company.
Electromed Shares Outstanding Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Electromed's direct or indirect competition against its Shares Outstanding to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Electromed could also be used in its relative valuation, which is a method of valuing Electromed by comparing valuation metrics of similar companies.Electromed is currently under evaluation in shares outstanding category among its peers.
Electromed Fundamentals
| Return On Equity | 0.17 | ||||
| Return On Asset | 0.11 | ||||
| Profit Margin | 0.12 % | ||||
| Operating Margin | 0.14 % | ||||
| Current Valuation | 136.8 M | ||||
| Shares Outstanding | 8.39 M | ||||
| Shares Owned By Insiders | 20.96 % | ||||
| Shares Owned By Institutions | 52.29 % | ||||
| Number Of Shares Shorted | 271.39 K | ||||
| Price To Earning | 23.66 X | ||||
| Price To Book | 3.46 X | ||||
| Price To Sales | 2.47 X | ||||
| Revenue | 54.72 M | ||||
| Gross Profit | 47.65 M | ||||
| EBITDA | 7.42 M | ||||
| Net Income | 5.15 M | ||||
| Cash And Equivalents | 8.15 M | ||||
| Cash Per Share | 0.96 X | ||||
| Total Debt | 87 K | ||||
| Debt To Equity | 0 % | ||||
| Current Ratio | 4.83 X | ||||
| Book Value Per Share | 5.16 X | ||||
| Cash Flow From Operations | 9.07 M | ||||
| Short Ratio | 2.23 X | ||||
| Earnings Per Share | 0.79 X | ||||
| Target Price | 32.0 | ||||
| Number Of Employees | 174 | ||||
| Beta | 0.41 | ||||
| Market Capitalization | 152.04 M | ||||
| Total Asset | 52.23 M | ||||
| Retained Earnings | 23.67 M | ||||
| Working Capital | 36.5 M | ||||
| Current Asset | 15.82 M | ||||
| Current Liabilities | 3.07 M | ||||
| Net Asset | 52.23 M |
About Electromed Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Electromed's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Electromed using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Electromed based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether Electromed is a strong investment it is important to analyze Electromed's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Electromed's future performance. For an informed investment choice regarding Electromed Stock, refer to the following important reports:Check out Electromed Piotroski F Score and Electromed Altman Z Score analysis. For information on how to trade Electromed Stock refer to our How to Trade Electromed Stock guide.You can also try the Portfolio Diagnostics module to use generated alerts and portfolio events aggregator to diagnose current holdings.
Is Medical Equipment space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Electromed. If investors know Electromed will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Electromed listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Electromed is measured differently than its book value, which is the value of Electromed that is recorded on the company's balance sheet. Investors also form their own opinion of Electromed's value that differs from its market value or its book value, called intrinsic value, which is Electromed's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Electromed's market value can be influenced by many factors that don't directly affect Electromed's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Electromed's value and its price as these two are different measures arrived at by different means. Investors typically determine if Electromed is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Electromed's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.